Negotiated Procedure Without Notice Pursuant To Art. 50, Paragraph 1, Lett. E) Of The Legislative Decree. 36/2023 And S.M.I. For The Two-Year Supply In The Administration Regime Referring To The Active Ingredients “Tetracosactide Acetate” Injectable Solution Vial Of 0.25 Mg/Ml Atc - H01Aa02 – “Tamsulosin “ Cpr/Cps Of 0.4 Mg - Atc G04Ca02 – “Triamcinolone” Suspension For Injection, Faiala 40Mg/Ml Atc – H02Ab08- “Fluconazole” Cps/Cpr 150 Mg Atc – J02Ac01- “Misoprostol” Cpr 200 Mcg Atc – A02Bb01- “Dutasteride” Cps/Cpr 0.5 Mg Atc- G04Cb02- “Minocicline” Cps 100 Mg Atc – J01Aa08-.